Trump Vows Pardon for Former Honduran President as Honduras Faces Tight Election 
Intel Boosts Malaysia Operations with Additional RM860 Million Investment 
Michael Dell Pledges $6.25 Billion to Boost Children’s Investment Accounts Under Trump Initiative 
Peru’s Ex-President Martín Vizcarra Sentenced to 14 Years in Prison for Corruption 
Netanyahu Requests Presidential Pardon Amid Ongoing Corruption Trial 
IKEA Launches First New Zealand Store, Marking Expansion Into Its 64th Global Market 
Judge Dismisses Charges Against Comey and Letitia James After Ruling on Prosecutor’s Appointment 
Apple Appoints Amar Subramanya as New Vice President of AI Amid Push to Accelerate Innovation 
Wikipedia Pushes for AI Licensing Deals as Jimmy Wales Calls for Fair Compensation 
UN General Assembly Demands Russia Return Ukrainian Children Amid Ongoing Conflict 
EU Prepares Antitrust Probe Into Meta’s AI Integration on WhatsApp 
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits 
Hikvision Challenges FCC Rule Tightening Restrictions on Chinese Telecom Equipment 
Bolsonaro Blames Medication Mix-Up for Ankle Monitor Tampering as Detention Continues 
Bristol Myers Faces $6.7 Billion Lawsuit After Judge Allows Key Shareholder Claims to Proceed 
Microchip Technology Boosts Q3 Outlook on Strong Bookings Momentum 
CFPB Reaches $1.75 Million Settlement with MoneyLion Over Military Loan Overcharges 
 to Recover Losses Announced by Shareholders Foundation - EconoTimes)
The Shareholders Foundation, Inc. announces that a lawsuit was filed in Oregon on behalf of certain purchasers of shares of GNC Holdings Inc (NYSE:GNC) over alleged Securities Laws Violations by GNC Holdings.
Investors who purchased shares of GNC Holdings Inc (NYSE:GNC) have certain options and for certain investors are short and strict deadlines running. Deadline: December 28, 2015. NYSE: GNC investors should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
The plaintiff claims that the defendants issued materially false and misleading statements to investors and/or failed to disclose that GNC Holdings unlawfully sold thousands of units of products in Oregon that contained picamilon, that GNC Holdings unlawfully sold thousands of units of products in Oregon that contained BMPEA, and that as a result of the foregoing, GNC Holdings’ public statements were materially false and misleading at all relevant times.
On October 22, 2015, the State of Oregon sued GNC Holdings Inc, claiming that the company's nutritional and dietary supplements are laced with unapproved drugs, including picamilon and BMPEA. According to the complaint GNC Holdings Inc violated the Oregon Unlawful Trade Practices ACT (“UTPA”) by misrepresenting some of its products as lawful dietary supplements. The complaint alleges that certain products that were misrepresented are unapproved drugs that may not be lawfully sold in the United States as a dietary supplement. In addition, the complaint alleged that GNC Holdings Inc sold products labeled containing botanical acacia rigidula that were added with unlabeled BMPEA and that GNC Holdings Inc allegedly sold thousands of units of products containing picamilon or BMPEA that were falsely labeled as a dietary supplement.
Those who purchased GNC Holdings Inc (NYSE:GNC) shares have certain options and should contact the Shareholders Foundation, Inc. by e-mail at [email protected] or call +1 (858) 779-1554.
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
